Global Cell and Gene Therapy CRO Supply, Demand and Key Producers, 2024-2030

Description

A Cell and Gene Therapy Contract Research Organization (CRO) is a specialized service provider that offers support and expertise in conducting preclinical and clinical research for cell and gene therapy products. These CROs play a crucial role in advancing the development of cell and gene therapies by providing a wide range of services tailored to the unique requirements of these innovative treatments.

The global Cell and Gene Therapy CRO market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Cell and Gene Therapy CRO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CRO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CRO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy CRO total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy CRO total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy CRO total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy CRO revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy CRO total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy CRO total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cell and Gene Therapy CRO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy CRO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy CRO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy CRO Market, Segmentation by Type
    Preclinical CRO
    Clinical CRO

Global Cell and Gene Therapy CRO Market, Segmentation by Application:
    SMBs
    Large Companies

Companies Profiled:
    Labcorp
    IQVIA Biotech
    PPD
    Medpace
    Veristat
    Parexel
    Charles River Laboratories
    Catalent Pharma Solutions
    Premier Research
    Catalent
    Vial
    Noble Life Sciences
    Ergomed

Key Questions Answered
1. How big is the global Cell and Gene Therapy CRO market?
2. What is the demand of the global Cell and Gene Therapy CRO market?
3. What is the year over year growth of the global Cell and Gene Therapy CRO market?
4. What is the total value of the global Cell and Gene Therapy CRO market?
5. Who are the Major Players in the global Cell and Gene Therapy CRO market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy CRO Introduction
    1.2 World Cell and Gene Therapy CRO Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy CRO Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy CRO Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.3 China Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.4 Europe Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.5 Japan Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.6 South Korea Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.7 ASEAN Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
        1.3.8 India Based Company Cell and Gene Therapy CRO Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy CRO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy CRO Consumption Value by Region
        2.2.1 World Cell and Gene Therapy CRO Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy CRO Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy CRO Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy CRO Consumption Value (2019-2030)

3 World Cell and Gene Therapy CRO Companies Competitive Analysis
    3.1 World Cell and Gene Therapy CRO Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy CRO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy CRO in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy CRO in 2023
    3.3 Cell and Gene Therapy CRO Company Evaluation Quadrant
    3.4 Cell and Gene Therapy CRO Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy CRO Market: Region Footprint
        3.4.2 Cell and Gene Therapy CRO Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy CRO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy CRO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy CRO Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy CRO Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy CRO Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy CRO Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy CRO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy CRO Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy CRO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy CRO Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy CRO Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy CRO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy CRO Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy CRO Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy CRO Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy CRO Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy CRO Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Preclinical CRO
        5.2.2 Clinical CRO
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy CRO Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy CRO Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy CRO Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy CRO Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 SMBs
        6.2.2 Large Companies
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy CRO Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy CRO Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy CRO Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Labcorp
        7.1.1 Labcorp Details
        7.1.2 Labcorp Major Business
        7.1.3 Labcorp Cell and Gene Therapy CRO Product and Services
        7.1.4 Labcorp Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Labcorp Recent Developments/Updates
        7.1.6 Labcorp Competitive Strengths & Weaknesses
    7.2 IQVIA Biotech
        7.2.1 IQVIA Biotech Details
        7.2.2 IQVIA Biotech Major Business
        7.2.3 IQVIA Biotech Cell and Gene Therapy CRO Product and Services
        7.2.4 IQVIA Biotech Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 IQVIA Biotech Recent Developments/Updates
        7.2.6 IQVIA Biotech Competitive Strengths & Weaknesses
    7.3 PPD
        7.3.1 PPD Details
        7.3.2 PPD Major Business
        7.3.3 PPD Cell and Gene Therapy CRO Product and Services
        7.3.4 PPD Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 PPD Recent Developments/Updates
        7.3.6 PPD Competitive Strengths & Weaknesses
    7.4 Medpace
        7.4.1 Medpace Details
        7.4.2 Medpace Major Business
        7.4.3 Medpace Cell and Gene Therapy CRO Product and Services
        7.4.4 Medpace Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Medpace Recent Developments/Updates
        7.4.6 Medpace Competitive Strengths & Weaknesses
    7.5 Veristat
        7.5.1 Veristat Details
        7.5.2 Veristat Major Business
        7.5.3 Veristat Cell and Gene Therapy CRO Product and Services
        7.5.4 Veristat Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Veristat Recent Developments/Updates
        7.5.6 Veristat Competitive Strengths & Weaknesses
    7.6 Parexel
        7.6.1 Parexel Details
        7.6.2 Parexel Major Business
        7.6.3 Parexel Cell and Gene Therapy CRO Product and Services
        7.6.4 Parexel Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Parexel Recent Developments/Updates
        7.6.6 Parexel Competitive Strengths & Weaknesses
    7.7 Charles River Laboratories
        7.7.1 Charles River Laboratories Details
        7.7.2 Charles River Laboratories Major Business
        7.7.3 Charles River Laboratories Cell and Gene Therapy CRO Product and Services
        7.7.4 Charles River Laboratories Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Charles River Laboratories Recent Developments/Updates
        7.7.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.8 Catalent Pharma Solutions
        7.8.1 Catalent Pharma Solutions Details
        7.8.2 Catalent Pharma Solutions Major Business
        7.8.3 Catalent Pharma Solutions Cell and Gene Therapy CRO Product and Services
        7.8.4 Catalent Pharma Solutions Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Catalent Pharma Solutions Recent Developments/Updates
        7.8.6 Catalent Pharma Solutions Competitive Strengths & Weaknesses
    7.9 Premier Research
        7.9.1 Premier Research Details
        7.9.2 Premier Research Major Business
        7.9.3 Premier Research Cell and Gene Therapy CRO Product and Services
        7.9.4 Premier Research Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Premier Research Recent Developments/Updates
        7.9.6 Premier Research Competitive Strengths & Weaknesses
    7.10 Catalent
        7.10.1 Catalent Details
        7.10.2 Catalent Major Business
        7.10.3 Catalent Cell and Gene Therapy CRO Product and Services
        7.10.4 Catalent Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Catalent Recent Developments/Updates
        7.10.6 Catalent Competitive Strengths & Weaknesses
    7.11 Vial
        7.11.1 Vial Details
        7.11.2 Vial Major Business
        7.11.3 Vial Cell and Gene Therapy CRO Product and Services
        7.11.4 Vial Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Vial Recent Developments/Updates
        7.11.6 Vial Competitive Strengths & Weaknesses
    7.12 Noble Life Sciences
        7.12.1 Noble Life Sciences Details
        7.12.2 Noble Life Sciences Major Business
        7.12.3 Noble Life Sciences Cell and Gene Therapy CRO Product and Services
        7.12.4 Noble Life Sciences Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Noble Life Sciences Recent Developments/Updates
        7.12.6 Noble Life Sciences Competitive Strengths & Weaknesses
    7.13 Ergomed
        7.13.1 Ergomed Details
        7.13.2 Ergomed Major Business
        7.13.3 Ergomed Cell and Gene Therapy CRO Product and Services
        7.13.4 Ergomed Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Ergomed Recent Developments/Updates
        7.13.6 Ergomed Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy CRO Industry Chain
    8.2 Cell and Gene Therapy CRO Upstream Analysis
    8.3 Cell and Gene Therapy CRO Midstream Analysis
    8.4 Cell and Gene Therapy CRO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Cell and Gene Therapy CRO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Cell and Gene Therapy CRO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Cell and Gene Therapy CRO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Cell and Gene Therapy CRO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Cell and Gene Therapy CRO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Cell and Gene Therapy CRO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Cell and Gene Therapy CRO Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Cell and Gene Therapy CRO Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Cell and Gene Therapy CRO Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Cell and Gene Therapy CRO Players in 2023
 Table 12. World Cell and Gene Therapy CRO Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Cell and Gene Therapy CRO Company Evaluation Quadrant
 Table 14. Head Office of Key Cell and Gene Therapy CRO Players
 Table 15. Cell and Gene Therapy CRO Market: Company Product Type Footprint
 Table 16. Cell and Gene Therapy CRO Market: Company Product Application Footprint
 Table 17. Cell and Gene Therapy CRO Mergers & Acquisitions Activity
 Table 18. United States VS China Cell and Gene Therapy CRO Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Cell and Gene Therapy CRO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Cell and Gene Therapy CRO Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Cell and Gene Therapy CRO Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Cell and Gene Therapy CRO Revenue Market Share (2019-2024)
 Table 23. China Based Cell and Gene Therapy CRO Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Cell and Gene Therapy CRO Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Cell and Gene Therapy CRO Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Cell and Gene Therapy CRO Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Cell and Gene Therapy CRO Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Cell and Gene Therapy CRO Revenue Market Share (2019-2024)
 Table 29. World Cell and Gene Therapy CRO Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Cell and Gene Therapy CRO Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Cell and Gene Therapy CRO Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Cell and Gene Therapy CRO Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Cell and Gene Therapy CRO Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Cell and Gene Therapy CRO Market Size by Application (2025-2030) & (USD Million)
 Table 35. Labcorp Basic Information, Manufacturing Base and Competitors
 Table 36. Labcorp Major Business
 Table 37. Labcorp Cell and Gene Therapy CRO Product and Services
 Table 38. Labcorp Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Labcorp Recent Developments/Updates
 Table 40. Labcorp Competitive Strengths & Weaknesses
 Table 41. IQVIA Biotech Basic Information, Manufacturing Base and Competitors
 Table 42. IQVIA Biotech Major Business
 Table 43. IQVIA Biotech Cell and Gene Therapy CRO Product and Services
 Table 44. IQVIA Biotech Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. IQVIA Biotech Recent Developments/Updates
 Table 46. IQVIA Biotech Competitive Strengths & Weaknesses
 Table 47. PPD Basic Information, Manufacturing Base and Competitors
 Table 48. PPD Major Business
 Table 49. PPD Cell and Gene Therapy CRO Product and Services
 Table 50. PPD Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. PPD Recent Developments/Updates
 Table 52. PPD Competitive Strengths & Weaknesses
 Table 53. Medpace Basic Information, Manufacturing Base and Competitors
 Table 54. Medpace Major Business
 Table 55. Medpace Cell and Gene Therapy CRO Product and Services
 Table 56. Medpace Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Medpace Recent Developments/Updates
 Table 58. Medpace Competitive Strengths & Weaknesses
 Table 59. Veristat Basic Information, Manufacturing Base and Competitors
 Table 60. Veristat Major Business
 Table 61. Veristat Cell and Gene Therapy CRO Product and Services
 Table 62. Veristat Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Veristat Recent Developments/Updates
 Table 64. Veristat Competitive Strengths & Weaknesses
 Table 65. Parexel Basic Information, Manufacturing Base and Competitors
 Table 66. Parexel Major Business
 Table 67. Parexel Cell and Gene Therapy CRO Product and Services
 Table 68. Parexel Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Parexel Recent Developments/Updates
 Table 70. Parexel Competitive Strengths & Weaknesses
 Table 71. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
 Table 72. Charles River Laboratories Major Business
 Table 73. Charles River Laboratories Cell and Gene Therapy CRO Product and Services
 Table 74. Charles River Laboratories Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Charles River Laboratories Recent Developments/Updates
 Table 76. Charles River Laboratories Competitive Strengths & Weaknesses
 Table 77. Catalent Pharma Solutions Basic Information, Manufacturing Base and Competitors
 Table 78. Catalent Pharma Solutions Major Business
 Table 79. Catalent Pharma Solutions Cell and Gene Therapy CRO Product and Services
 Table 80. Catalent Pharma Solutions Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Catalent Pharma Solutions Recent Developments/Updates
 Table 82. Catalent Pharma Solutions Competitive Strengths & Weaknesses
 Table 83. Premier Research Basic Information, Manufacturing Base and Competitors
 Table 84. Premier Research Major Business
 Table 85. Premier Research Cell and Gene Therapy CRO Product and Services
 Table 86. Premier Research Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Premier Research Recent Developments/Updates
 Table 88. Premier Research Competitive Strengths & Weaknesses
 Table 89. Catalent Basic Information, Manufacturing Base and Competitors
 Table 90. Catalent Major Business
 Table 91. Catalent Cell and Gene Therapy CRO Product and Services
 Table 92. Catalent Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Catalent Recent Developments/Updates
 Table 94. Catalent Competitive Strengths & Weaknesses
 Table 95. Vial Basic Information, Manufacturing Base and Competitors
 Table 96. Vial Major Business
 Table 97. Vial Cell and Gene Therapy CRO Product and Services
 Table 98. Vial Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Vial Recent Developments/Updates
 Table 100. Vial Competitive Strengths & Weaknesses
 Table 101. Noble Life Sciences Basic Information, Manufacturing Base and Competitors
 Table 102. Noble Life Sciences Major Business
 Table 103. Noble Life Sciences Cell and Gene Therapy CRO Product and Services
 Table 104. Noble Life Sciences Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Noble Life Sciences Recent Developments/Updates
 Table 106. Noble Life Sciences Competitive Strengths & Weaknesses
 Table 107. Ergomed Basic Information, Manufacturing Base and Competitors
 Table 108. Ergomed Major Business
 Table 109. Ergomed Cell and Gene Therapy CRO Product and Services
 Table 110. Ergomed Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Ergomed Recent Developments/Updates
 Table 112. Ergomed Competitive Strengths & Weaknesses
 Table 113. Global Key Players of Cell and Gene Therapy CRO Upstream (Raw Materials)
 Table 114. Global Cell and Gene Therapy CRO Typical Customers


List of Figures
 Figure 1. Cell and Gene Therapy CRO Picture
 Figure 2. World Cell and Gene Therapy CRO Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Cell and Gene Therapy CRO Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Cell and Gene Therapy CRO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Cell and Gene Therapy CRO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Cell and Gene Therapy CRO Revenue (2019-2030) & (USD Million)
 Figure 13. Cell and Gene Therapy CRO Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Cell and Gene Therapy CRO Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Cell and Gene Therapy CRO by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy CRO Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy CRO Markets in 2023
 Figure 27. United States VS China: Cell and Gene Therapy CRO Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Cell and Gene Therapy CRO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Cell and Gene Therapy CRO Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Cell and Gene Therapy CRO Market Size Market Share by Type in 2023
 Figure 31. Preclinical CRO
 Figure 32. Clinical CRO
 Figure 33. World Cell and Gene Therapy CRO Market Size Market Share by Type (2019-2030)
 Figure 34. World Cell and Gene Therapy CRO Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Cell and Gene Therapy CRO Market Size Market Share by Application in 2023
 Figure 36. SMBs
 Figure 37. Large Companies
 Figure 38. World Cell and Gene Therapy CRO Market Size Market Share by Application (2019-2030)
 Figure 39. Cell and Gene Therapy CRO Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Companies Mentioned

Labcorp
IQVIA Biotech
PPD
Medpace
Veristat
Parexel
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed